Regulatory Filings • Oct 25, 2018
Preview not available for this file type.
Download Source FileDEFA14A 1 defa14a102518_chinapharma.htm DEFINITIVE ADDITIONAL MATERIALS
Field: Rule-Page
Field: /Rule-Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed by the Registrant þ
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
|---|---|
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a- 6(e)(2) ) |
| ☐ | Definitive Proxy Statement |
| þ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to §240.14a-12 |
CHINA PHARMA HOLDINGS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| þ | No fee required. |
|---|---|
| ☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
| (1) | Title of each class of securities to which transaction applies: |
|---|---|
| (2) | Aggregate number of securities to which transaction applies: |
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
| (4) | Proposed maximum aggregate value of transaction: |
| (5) | Total fee paid: |
| ☐ | Fee paid previously with preliminary materials. |
|---|---|
| ☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
| (1) | Amount Previously Paid: |
|---|---|
| (2) | Form, Schedule or Registration Statement No.: |
| (3) | Filing Party: |
| (4) | Date Filed: |
Field: Rule-Page
Field: /Rule-Page
Field: Page; Sequence: 1
Field: /Page
| CHINA
PHARMA HOLDINGS, INC. |
| --- |
| REQUEST
ID: |
| IMPORTANT
NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS for the Annual Meeting of Stockholders |
| | DATE: — TIME: | December
5, 2018 (local time), December 4, 2018 (eastern time) — 9:00
a.m. local time, 8:00 pm eastern time | |
| --- | --- | --- | --- |
| | LOCATION: | Conference
Room, 2nd Floor, Jiahai Building, No. 17 Jinpan Road, Haikou, Hainan Province, China 570216 | |
| HOW
TO REQUEST PAPER COPIES OF OUR MATERIALS | | | |
| ● | ● | ● | ● |
| PHONE: Call
toll free 1-866-752-8683 | FAX: Send
this card to 202-521-3464 | INTERNET: https://www.iproxydirect.com/CPHI and follow the on-screen instructions. | EMAIL: [email protected] Include your Control ID in your email. |
| This
communication represents a notice to access a more complete set of proxy materials available to you on the Internet. We encourage
you to access and review all of the important information contained in the proxy materials before voting. The proxy statement
is available at: https://www.iproxydirect.com/CPHI |
| --- |
| If
you want to receive a paper copy of the proxy materials you must request one. There is no charge to you for requesting a copy.
To facilitate timely delivery please make the request, as instructed above, before November 23, 2018. |
| you
may enter your voting instructions at https://www.iproxydirect.com /CPHI until 11:59 pm eastern time December 3, 2018 |
| The
purposes of this meeting are as follows: |
| --- |
| 1. To elect five director nominees to our Board of Directors to serve until the
next annual meeting (for non-executive directors) or until the annual meeting in three
years (for executive directors) and until their successors are elected and qualified;
and 2. To transact such other business as may properly come before the Annual Meeting or any adjournment thereof. |
| Pursuant
to Securities and Exchange Commission rules, you are receiving this Notice that the proxy
materials for the Annual meeting are available on the Internet. Follow the instructions
above to view the materials and vote or request printed copies. The
board of directors has fixed the close of business on October 15, 2018 as the record date for the determination of stockholders
entitled to receive notice of the Annual Meeting and to vote the shares of our common stock and Series A Convertible Preferred
Stock. |
| --- |
| THE
BOARD, INCLUDING THE INDEPENDENT DIRECTORS, UNANIMOUSLY RECOMMENDS THAT YOU VOTE “ FOR
ALL ” EACH OF THE NOMINEES IN PROPOSAL ONE. |
| Please note - This
is not a Proxy Card - you cannot vote by returning this card |
Field: Page; Sequence: 1
Field: /Page
CHINA PHARMA HOLDINGS, INC. SHAREHOLDER SERVICES 500 Perimeter Park Drive Suite D Morrisville NC 27560 FIRST-CLASS MAIL US POSTAGE PAID RALEIGH NC PERMIT # 870
Time Sensitive shareholder information enclosed
IMPORTANT SHAREHOLDER INFORMATION
your vote is important
Field: Page; Sequence: 2
Field: /Page
| CHINA
PHARMA HOLDINGS, INC. THIS
PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS annual
meeting OF STOCKHOLDERS – december
4, 2018 at 8:00 p.m. Eastern Time (December 5, 2018 at 9:00 a.m. local time) | | |
| --- | --- | --- |
| CONTROL
ID: | | |
| REQUEST
ID: | | |
| This
Proxy is Solicited on Behalf of the Board of Directors of China Pharma
Holdings, Inc. The undersigned hereby appoints Zhilin
Li as proxy, with full power of substitution, to vote as designated below all of the shares the undersigned is entitled to
vote at the Annual Meeting of Stockholders to be held at the Conference Room, 2nd Floor, Jiahai Building, No. 17 Jinpan Road,
Haikou, Hainan Province, China 570216 on Wednesday, December 5, 2018, at 9:00 a.m. local time (Tuesday, December 4, 2018 at
8:00 p.m., Eastern Time), and any adjournments or postponements thereof, and otherwise to represent the undersigned at the
meeting, with all powers possessed by the undersigned if personally present at the meeting. | | |
| (CONTINUED
AND TO BE SIGNED ON REVERSE SIDE.) | | |
| VOTING
INSTRUCTIONS | | |
| If you
vote by phone, fax or internet, please DO NOT mail your proxy card. | | |
| ● | MAIL: | Please mark, sign, date, and
return this Proxy Card promptly using the enclosed envelope. |
| ● | FAX: | Complete the reverse portion
of this Proxy Card and Fax to 202-521-3464. |
| ● | INTERNET: | https://www.iproxydirect.com/CPHI |
| ● | PHONE: | 1-866-752-VOTE(8683) |
Field: Page; Sequence: 2
Field: /Page
| ANNUAL
MEETING OF THE STOCKHOLDERS OF CHINA PHARMA HOLDINGS, INC. | | PLEASE
COMPLETE, DATE, SIGN AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE: ☒ | | | |
| --- | --- | --- | --- | --- | --- |
| PROXY
SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS | | | | | |
| Proposal 1 | à | FOR ALL | AGAINST ALL | FOR
ALL EXCEPT | |
| To elect five director nominees to our Board of Directors to
serve until the next annual meeting (for non-executive directors) or until the annual meeting in three years (for executive
directors) and until their successors are elected and qualified: | | ☐ | ☐ | | |
| Zhilin Li | | | | ☐ | |
| Heung Mei Tsui | | | | ☐ | Control ID: |
| Gene Michael Bennett | | | | ☐ | REQUEST ID: |
| Yingwen Zhang | | | | ☐ | |
| Baowen Dong | | | | ☐ | |
| Proposal 2 | | | | | |
| To transact such other business as may
properly come before the Annual Meeting or any adjournment thereof. | | | | | |
| | | | MARK “X” HERE IF YOU
PLAN TO ATTEND THE MEETING: ☐ | | |
| Our
Board of Directors recommends a vote “FOR ALL” election of each of the nominees listed in Proposal
1. | | | MARK
HERE FOR ADDRESS CHANGE ☐ New Address (if
applicable): ____ ____ ____ IMPORTANT: Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign.
When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer
is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is
a partnership, please sign in partnership name by authorized person. Dated: ______,
2018 | | |
| | | | (Print
Name of Stockholder and/or Joint Tenant) | | |
| | | | (Signature
of Stockholder) | | |
| | | | (Second Signature if held jointly) | | |
Field: Rule-Page
Field: /Rule-Page
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.